Your browser doesn't support javascript.
loading
Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection.
Lambert, Christophe; Braxton, Cassandra; Charlebois, Robert L; Deyati, Avisek; Duncan, Paul; La Neve, Fabio; Malicki, Heather D; Ribrioux, Sebastien; Rozelle, Daniel K; Michaels, Brandye; Sun, Wenping; Yang, Zhihui; Khan, Arifa S.
Afiliação
  • Lambert C; GSK, 1330 Rixensart, Belgium. christophe.g.lambert@gsk.com.
  • Braxton C; Biogen Inc., Research Triangle Park, NC 27709, USA. cassandra.braxton@biogen.com.
  • Charlebois RL; Analytical Research and Development, Sanofi Pasteur, Toronto, ON M2R 3T4, Canada. Robert.Charlebois@sanofi.com.
  • Deyati A; GSK, 1330 Rixensart, Belgium. avis.quest@gmail.com.
  • Duncan P; Merck & Co. Inc., West Point, PA 19486, USA. paul_duncan@merck.com.
  • La Neve F; Merck KGaA, 10010 Torino, Italy. fabioinusa@gmail.com.
  • Malicki HD; WuXi AppTec, Philadelphia, PA 19112, USA. Heather.Malicki@wuxiapptec.com.
  • Ribrioux S; Genedata AG, 4053 Basel, Switzerland. sebastien.ribrioux@genedata.com.
  • Rozelle DK; Radiant Systems, Inc., Plainfield, NJ 07080, USA. dan.rozelle@gmail.com.
  • Michaels B; Analytical Research and Development: Microbiology, Pfizer Inc., Andover, MA 01810, USA. Brandye.Michaels@pfizer.com.
  • Sun W; WuXi AppTec, Philadelphia, PA 19112, USA. kathryn.sun@gmail.com.
  • Yang Z; Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD 20708, USA. Zhihui.Yang@fda.hhs.gov.
  • Khan AS; Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Arifa.Khan@fda.hhs.gov.
Viruses ; 10(10)2018 09 27.
Article em En | MEDLINE | ID: mdl-30262776
High-throughput sequencing (HTS) has demonstrated capabilities for broad virus detection based upon discovery of known and novel viruses in a variety of samples, including clinical, environmental, and biological. An important goal for HTS applications in biologics is to establish parameter settings that can afford adequate sensitivity at an acceptable computational cost (computation time, computer memory, storage, expense or/and efficiency), at critical steps in the bioinformatics pipeline, including initial data quality assessment, trimming/cleaning, and assembly (to reduce data volume and increase likelihood of appropriate sequence identification). Additionally, the quality and reliability of the results depend on the availability of a complete and curated viral database for obtaining accurate results; selection of sequence alignment programs and their configuration, that retains specificity for broad virus detection with reduced false-positive signals; removal of host sequences without loss of endogenous viral sequences of interest; and use of a meaningful reporting format, which can retain critical information of the analysis for presentation of readily interpretable data and actionable results. Furthermore, after alignment, both automated and manual evaluation may be needed to verify the results and help assign a potential risk level to residual, unmapped reads. We hope that the collective considerations discussed in this paper aid toward optimization of data analysis pipelines for virus detection by HTS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus / DNA Viral / RNA Viral / Biologia Computacional / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus / DNA Viral / RNA Viral / Biologia Computacional / Sequenciamento de Nucleotídeos em Larga Escala Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article